(Q51218663)

1 April 2018

title

Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis. (English)

1 reference

1 April 2018

1 reference

1 reference

Sibel Samdancioglu

1

1 reference

1 April 2018

Sema Calis

series ordinal

2

1 reference

1 April 2018

Murat Sumnu

series ordinal

3

1 reference

1 April 2018

A Atilla Hincal

series ordinal

4

1 reference

1 April 2018

language of work or name

English

0 references

publication date

1 April 2006

1 reference

1 April 2018

Drug Development and Industrial Pharmacy

published in

1 reference

1 April 2018

volume

32

1 reference

1 April 2018

issue

4

1 reference

1 April 2018

page(s)

473-481

1 reference

1 April 2018

Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Novel crosslinking methods to design hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Preparation of microspheres by the solvent evaporation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Long-term release of clodronate from biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Alendronate: an update of its use in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500528871

10.1080/03639040500528871

21 January 2018

Identifiers

DOI

1 reference

1 April 2018

PubMed ID

16638686

1 reference

1 April 2018